Table 2. Histologic findings of patients with secondary MN.
Patient | Cause of secondary MN | Anti-PLA2R | Subepithelial deposits | Subendothelial deposits | IgG4 deposits | Mesangial deposits | C1q deposits |
S1 | Malignancy | + | + | – | + | + | – |
S2 | HBV | + | + | – | + | + | – |
S3 | HBV | – | + | – | – | + | + |
S4 | HBV | – | + | – | – | – | + |
S5 | HBV | – | + | + | ± | – | + |
S6 | HBV | – | + | – | – | – | + |
S7 | HCV | – | + | + | – | – | + |
S8 | Lupus | – | + | + | – | + | + |
S9 | Malignancy | – | + | – | – | – | – |
MN, membranous nephropathy; Anti-PLA2R, anti-phospholipase A2 receptor antibody; HBV, hepatitis B virus; HCV, hepatitis C virus.